Literature DB >> 24286577

The sympathetic nervous system and heart failure.

David Y Zhang1, Allen S Anderson.   

Abstract

Heart failure (HF) is a syndrome characterized by upregulation of the sympathetic nervous system and abnormal responsiveness of the parasympathetic nervous system. Studies in the 1980s and 1990s demonstrated that inhibition of the renin-angiotensin-aldosterone system with angiotensin-converting enzyme inhibitors improved symptoms and mortality in HF resulting from systolic dysfunction, thus providing a framework to consider the use of β-blockers for HF therapy, contrary to the prevailing wisdom of the time. Against this backdrop, this article reviews the contemporary understanding of the sympathetic nervous system and the failing heart.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Heart failure; Neurohormone; Renin-angiotensin-aldosterone; Sympathetic nervous system

Mesh:

Substances:

Year:  2014        PMID: 24286577      PMCID: PMC5873965          DOI: 10.1016/j.ccl.2013.09.010

Source DB:  PubMed          Journal:  Cardiol Clin        ISSN: 0733-8651            Impact factor:   2.213


  66 in total

1.  A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure.

Authors:  Eric J Eichhorn; Michael J Domanski; Heidi Krause-Steinrauf; Michael R Bristow; Philip W Lavori
Journal:  N Engl J Med       Date:  2001-05-31       Impact factor: 91.245

Review 2.  Expert consensus document on beta-adrenergic receptor blockers.

Authors:  José López-Sendón; Karl Swedberg; John McMurray; Juan Tamargo; Aldo P Maggioni; Henry Dargie; Michal Tendera; Finn Waagstein; Jan Kjekshus; Philippe Lechat; Christian Torp-Pedersen
Journal:  Eur Heart J       Date:  2004-08       Impact factor: 29.983

Review 3.  Oxidative stress and central cardiovascular regulation. - Pathogenesis of hypertension and therapeutic aspects -.

Authors:  Yoshitaka Hirooka; Yoji Sagara; Takuya Kishi; Kenji Sunagawa
Journal:  Circ J       Date:  2010-04-15       Impact factor: 2.993

4.  Comparison of muscle sympathetic activity in ischemic and nonischemic heart failure.

Authors:  Catherine F Notarius; Jonas Spaak; Beverley L Morris; John S Floras
Journal:  J Card Fail       Date:  2007-08       Impact factor: 5.712

5.  Inhibition of awake sympathetic nerve activity of heart failure patients with obstructive sleep apnea by nocturnal continuous positive airway pressure.

Authors:  Kengo Usui; T Douglas Bradley; Jonas Spaak; Clodagh M Ryan; Toshihiko Kubo; Yasuyuki Kaneko; John S Floras
Journal:  J Am Coll Cardiol       Date:  2005-06-21       Impact factor: 24.094

6.  Time course of sympathovagal imbalance and left ventricular dysfunction in conscious dogs with heart failure.

Authors:  H Ishise; H Asanoi; S Ishizaka; S Joho; T Kameyama; K Umeno; H Inoue
Journal:  J Appl Physiol (1985)       Date:  1998-04

7.  Influence of obstructive sleep apnea on mortality in patients with heart failure.

Authors:  Hanqiao Wang; John D Parker; Gary E Newton; John S Floras; Susanna Mak; Kuo-Liang Chiu; Pimon Ruttanaumpawan; George Tomlinson; T Douglas Bradley
Journal:  J Am Coll Cardiol       Date:  2007-04-02       Impact factor: 24.094

Review 8.  Central sympathetic overactivity: maladies and mechanisms.

Authors:  James P Fisher; Colin N Young; Paul J Fadel
Journal:  Auton Neurosci       Date:  2009-03-06       Impact factor: 3.145

9.  123I-mIBG scintigraphy to predict risk for adverse cardiac outcomes in heart failure patients: design of two prospective multicenter international trials.

Authors:  Arnold F Jacobson; John Lombard; Gopa Banerjee; Paolo G Camici
Journal:  J Nucl Cardiol       Date:  2009-01-20       Impact factor: 5.952

10.  Advantage of recording single-unit muscle sympathetic nerve activity in heart failure.

Authors:  Hisayoshi Murai; Masayuki Takamura; Shuichi Kaneko
Journal:  Front Physiol       Date:  2012-05-03       Impact factor: 4.566

View more
  34 in total

1.  Angiotensin Type 1 Receptors and Superoxide Anion Production in Hypothalamic Paraventricular Nucleus Contribute to Capsaicin-Induced Excitatory Renal Reflex and Sympathetic Activation.

Authors:  Yun Qiu; Fen Zheng; Chao Ye; Ai-Dong Chen; Jue-Jin Wang; Qi Chen; Yue-Hua Li; Yu-Ming Kang; Guo-Qing Zhu
Journal:  Neurosci Bull       Date:  2020-01-27       Impact factor: 5.203

2.  Symbolic dynamics to discriminate healthy and ischaemic dilated cardiomyopathy populations: an application to the variability of heart period and QT interval.

Authors:  José Fernando Valencia; Montserrat Vallverdu; Isidre Rivero; Andreas Voss; Antonio Bayes de Luna; Alberto Porta; Pere Caminal
Journal:  Philos Trans A Math Phys Eng Sci       Date:  2015-02-13       Impact factor: 4.226

Review 3.  Cardiac molecular imaging to track left ventricular remodeling in heart failure.

Authors:  Jamshid Shirani; Amitoj Singh; Sahil Agrawal; Vasken Dilsizian
Journal:  J Nucl Cardiol       Date:  2016-08-01       Impact factor: 5.952

Review 4.  The relationship of stress and blood pressure effectors.

Authors:  C Ayada; Ü Toru; Y Korkut
Journal:  Hippokratia       Date:  2015 Apr-Jun       Impact factor: 0.471

5.  Chemical Stimulation of Renal Tissue Induces Sympathetic Activation and a Pressor Response via the Paraventricular Nucleus in Rats.

Authors:  Chao Ye; Yun Qiu; Feng Zhang; Ai-Dong Chen; Hong Zhou; Jue-Jin Wang; Qi Chen; Yue-Hua Li; Yu-Ming Kang; Guo-Qing Zhu
Journal:  Neurosci Bull       Date:  2019-08-07       Impact factor: 5.203

Review 6.  New horizons in cardiac innervation imaging: introduction of novel 18F-labeled PET tracers.

Authors:  Ryohei Kobayashi; Xinyu Chen; Rudolf A Werner; Constantin Lapa; Mehrbod S Javadi; Takahiro Higuchi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-09-13       Impact factor: 9.236

7.  The association of beta-blocker use with mortality in elderly patients with congestive heart failure and advanced chronic kidney disease.

Authors:  Amber O Molnar; William Petrcich; Matthew A Weir; Amit X Garg; Michael Walsh; Manish M Sood
Journal:  Nephrol Dial Transplant       Date:  2020-05-01       Impact factor: 5.992

8.  Relationship of Cardiac Autonomic Modulation with Cardiovascular Parameters in Adults, According to Body Mass Index and Physical Activity.

Authors:  William R Tebar; Raphael M Ritti-Dias; Jorge Mota; Bruna T C Saraiva; Tatiana M Damato; Leandro D Delfino; Breno Q Farah; Luiz Carlos M Vanderlei; Diego G D Christofaro
Journal:  J Cardiovasc Transl Res       Date:  2021-01-22       Impact factor: 4.132

9.  Impairments in Blood Pressure Regulation and Cardiac Baroreceptor Sensitivity Among Patients With Heart Failure Supported With Continuous-Flow Left Ventricular Assist Devices.

Authors:  Christine Sailer; Hannah Edelmann; Cullen Buchanan; Pedro Giro; Matthew Babcock; Christine Swanson; Melanie Spotts; Margaret Schulte; Ashley Pratt-Cordova; Greg Coe; Mark Beindorff; Robert L Page; Amrut V Ambardekar; Jay D Pal; Wendy Kohrt; Eugene Wolfel; Justin S Lawley; Takashi Tarumi; William K Cornwell
Journal:  Circ Heart Fail       Date:  2021-01-19       Impact factor: 8.790

10.  Blockade of β-adrenergic signaling suppresses inflammasome and alleviates cardiac fibrosis.

Authors:  Shipeng Dang; Zhen-Ye Zhang; Ku-Lin Li; Jie Zheng; Ling-Ling Qian; Xiao-Yu Liu; Ying Wu; Chang-Ying Zhang; Xiao-Xi Zhao; Zhi-Ming Yu; Ru-Xing Wang; Tingbo Jiang
Journal:  Ann Transl Med       Date:  2020-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.